Division of Cardiology, The Lundquist Institute at Harbor-UCLA Medical Center, Los Angeles, California.
Harvard Medical School, Boston, Massachusetts.
Coron Artery Dis. 2024 Nov 1;35(7):577-583. doi: 10.1097/MCA.0000000000001395. Epub 2024 Jun 13.
BACKGROUND: Despite innovations in pharmacotherapy to lower lipoprotein cholesterol and apolipoprotein B, risk factors for atherosclerotic cardiovascular disease (ASCVD), ASCVD persists as the leading global cause of mortality. Elevations in low-density lipoprotein cholesterol (LDL-C) are a well-known risk factor and have been a main target in the treatment of ASCVD. The latest research suggests that ketogenic diets are effective at improving most non-LDL-C/apolipoprotein B cardiometabolic risk factors. However, ketogenic diets can induce large increases in LDL-C to >190 mg/dl in some individuals. Interestingly, these individuals are often otherwise lean and healthy. The influence of increased levels of LDL-C resulting from a carbohydrate-restricted ketogenic diet on the progression of atherosclerosis in otherwise metabolically healthy individuals is poorly understood. This observational study aims to assess and describe the progression of coronary atherosclerosis in this population within 12 months. METHODS: Hundred relatively lean individuals who adopted ketogenic diets and subsequently exhibited hypercholesterolemia with LDL-C to >190 mg/dl, in association with otherwise good metabolic health markers, were enrolled and observed over a period of 12 months. Participants underwent serial coronary computed tomography angiography scans to assess the progression of coronary atherosclerosis in a year. RESULTS: Data analysis shall begin following the conclusion of the trial with results to follow. CONCLUSION: Ketogenic diets have generated debate and raised concerns within the medical community, especially in the subset exhibiting immense elevations in LDL-C, who interestingly are lean and healthy. The relationship between elevated LDL-C and ASCVD progression in this population will provide better insight into the effects of diet-induced hypercholesterolemia.
背景:尽管在降低脂蛋白胆固醇和载脂蛋白 B 方面有药理学方面的创新,但动脉粥样硬化性心血管疾病 (ASCVD) 的风险因素仍然存在,ASCVD 仍然是全球主要的死亡原因。低密度脂蛋白胆固醇 (LDL-C) 升高是一个众所周知的风险因素,一直是 ASCVD 治疗的主要目标。最新的研究表明,生酮饮食在改善大多数非 LDL-C/载脂蛋白 B 心血管代谢危险因素方面非常有效。然而,生酮饮食会在某些个体中引起 LDL-C 大幅升高到>190mg/dl。有趣的是,这些个体通常体型偏瘦且健康。在代谢健康的个体中,碳水化合物限制的生酮饮食引起的 LDL-C 水平升高对动脉粥样硬化进展的影响知之甚少。本观察性研究旨在评估和描述在 12 个月内该人群中冠状动脉粥样硬化的进展情况。
方法:招募了 100 名相对偏瘦的个体,他们采用生酮饮食后出现 LDL-C 升高至>190mg/dl,同时伴有良好的代谢健康标志物,在 12 个月的时间内对他们进行了观察。参与者接受了连续的冠状动脉计算机断层扫描血管造影扫描,以评估在一年内冠状动脉粥样硬化的进展情况。
结果:数据分析将在试验结束后开始,随后将报告结果。
结论:生酮饮食在医学界引起了争议,并引起了关注,特别是在 LDL-C 大幅升高的亚组中,这些个体有趣的是体型偏瘦且健康。在该人群中,升高的 LDL-C 与 ASCVD 进展之间的关系将更好地了解饮食引起的高胆固醇血症的影响。
Eur J Prev Cardiol. 2024-10-24
Cochrane Database Syst Rev. 2016-2-9
Cochrane Database Syst Rev. 2012-3-14
Cell Biochem Biophys. 2025-8-29
Trends Cardiovasc Med. 2024-7
Front Psychiatry. 2022-7-6
Circ Cardiovasc Qual Outcomes. 2022-6